![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 16/28 | |
C07K 16/46 | |||
A61K 39/395 | |||
A61P 31/12 | |||
A61P 35/00 | |||
A61P 37/00 |
(11) | Number of the document | 2038306 |
(13) | Kind of document | T |
(96) | European patent application number | 07786885.9 |
Date of filing the European patent application | 2007-06-28 | |
(97) | Date of publication of the European application | 2009-03-25 |
(45) | Date of publication and mention of the grant of the patent | 2014-12-03 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2007/056485 |
Date | 2007-06-28 |
(87) | Number | WO 2008/009545 |
Date | 2008-01-24 |
(30) | Number | Date | Country code |
06116429 | 2006-06-30 | EP |
(72) |
SPEE, Petrus Johannes Louis, DK
PADKĘR, S ren Berg, DK
|
(73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
(54) | ANTI-NKG2A ANTIBODIES AND USES THEREOF |
ANTI-NKG2A ANTIBODIES AND USES THEREOF |